Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
BioNTech (BNTX US)
Watchlist
46
Analysis
Health Care
•
Germany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
23 Jun 2025 12:48
•
Syndicated
Chinese Biotech Innovators Push Overseas as Sector Faces Reckoning
After years of falling valuations and stalled IPO activity, China’s innovative drug industry is showing early signs of a comeback. A spate of...
Caixin Global
Follow
332 Views
Share
bullish
•
Cross Asset Strategy
•
23 Dec 2022 10:46
•
Syndicated
CX Daily: Why China’s Social Relief Efforts Have Fallen Short
Why China’s social relief efforts have fallen short. Germans will soon be able to access BioNTech shot on mainland, ambassador says. China,...
Caixin Global
Follow
748 Views
Share
bullish
•
Cross Asset Strategy
•
21 Dec 2022 10:21
•
Syndicated
CX Daily: What’s in Store for China GDP, Fiscal Policy in 2023
What’s in store for China GDP, fiscal policy in 2023. Hong Kong approval expands mainlanders’ access to mRNA Covid shots. Chinese exporters lose...
Caixin Global
Follow
600 Views
Share
bullish
•
Cross Asset Strategy
•
15 Dec 2022 14:11
•
Syndicated
CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations
Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...
Caixin Global
Follow
602 Views
Share
bullish
•
Melco Resorts & Entertainment
•
04 Dec 2022 10:26
•
Syndicated
Weekly Stock Bullfinder - Week of 12/5
As investors we are faced with a deluge of noisy breaking news, business media talking heads, and what has felt like non-stop Fed speakers offering...
Weekly Stock Bull Finder
Follow
608 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x